Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Botulinum toxin for Sialorrhea in Patients with Parkinson’s disease & Atypical Parkinsonism: A Single Center Real-World Study

Motor Outcomes to Validate Evaluations in Facioscapulohumeral muscular dystrophy (MOVE FSHD): Preliminary Baseline Characteristics

Author:Walker, Michaela   Butterfield, Russell   Day, John   Eichinger, Katy   Elsheikh, Bakri   Friedman, Seth   Genge, Angela   Higgs, Kiley   Johnson, Nicholas   Jones, Peter   Leung, Doris   Lewis, Leann   Lochmuller, Hanns   O'Ferrall, Erin   Martens, William   Shaw, Dennis   Shieh, Perry   Subramony, S   Trivedi, Jaya   Wang, Leo   Wicklund, Matthew   Tawil, Alrabi   Statland, Jeffrey   

Session Name:S7: Outcome Measures and Observational Studies of Neuromuscular Diseases  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S7.004  

Author Institution:University of Kansas Medical Center, Fairway, KS  University of Utah, Salt Lake City, UT  Stanford University School of Medicine, Palo Alto, CA  University of Rochester Medical Center, Rochester, NY  The Ohio State University Wexner Medical Center, Columbus, OH  Seattle Children's Hospital , Seattle, WA  Mcgill University, Montreal, QC, Canada  University of Kansas Medical Center, Kansas City, KS  Virginia Commonwealth University, Richmond, VA  University of Nevada Reno, Reno, NV  Kennedy Krieger Institute, Baltimore, MD  Children's Hospital of Eastern Ontario & Ottawa Hospital Research Institute , Ottawa, ON, Canada  McGill University & Montreal Neurological Institute, Montreal, QC, Canada  Seattle Children's Hospital, Seattle, WA  University of California Los Angeles, Los Angeles, CA  University of Florida, Gainesville, FL  University of Texas Southwestern Medical Center, Dallas, TX  University of Washington, Seattle, WA  University of Colorado, Aurora, CO  

Effect of complement C3 inhibition with pegcetacoplan in an iPSC-derived ALS neuromuscular junction model of neuroinflammation